Additional file 1 of Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma

Supplementary Material 1: Figure S1. Kaplan-Meier curves of OS differences in high- and low-risk groups. Figure S2. Prognostic validation of m6A-related lncRNAs in risk model in the TCGA entire sets. Figure S3. Prognostic validation of m6A-related lncRNAs in risk model in the test sets. Figure S4. Kaplan-Meier curves of OS differences layered by stage I-II (A), III-IV (B), M0 (C), M1 (D) between the high- and low-risk groups from TCGA data set. Supplementary Table 1. Primers applied to qPCR analyses